Lenvatinib
HCC-S051
Phase 3 small_molecule terminated
Quick answer
Lenvatinib for Hepatocellular Carcinoma is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Hepatocellular Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated